Overview
Alzheimer's disease (AD) is characterized by cognitive impairment and memory deficits. The disease also impacts cellular energy production and utilization within the brain. Mitochondria, which are responsible for generating cellular energy, can exhibit dysfunction in AD. Concurrently, alterations in cerebral blood flow and oxygen availability may impose additional stress on brain tissue. Investigating the interplay between these processes is crucial for characterizing the metabolic changes associated with AD.
Research Context
The established understanding of Alzheimer's disease primarily focuses on its neurological and cognitive effects. However, a significant aspect of the disease pathology involves metabolic dysregulation at the cellular level. Mitochondrial dysfunction is a recognized feature in AD, contributing to compromised energy supply within brain cells. Furthermore, systemic or local changes in blood flow dynamics and oxygen delivery can impact neuronal function and survival, potentially exacerbating metabolic challenges in the context of AD.
Why This Matters
Understanding how mitochondrial dysfunction and changes in oxygen availability interact in Alzheimer's disease could provide insights into the complex metabolic alterations that accompany the disease. Characterizing these metabolic changes may be instrumental for developing a more comprehensive understanding of AD progression and its underlying mechanisms.